BIT Capital’s Mereo BioPharma MREO Stock Holding History

BIT Capital’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-101,070	Closed	-$227K	–	107
2025 Q1	$227K	Buy	+101,070	New	+$286K	0.02%	97

Other funds holding MREO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT Capital's MREO Position: Q2 2025 in Review

BIT Capital sold out of Mereo BioPharma (MREO) in Q2 2025, closing a stake of 101,070 shares — an estimated $227K sold.

BIT Capital first reported a position in MREO in Q1 2025 and held it in 1 quarter. The position peaked at $227K in Q1 2025. 86 funds tracked by Wall St. Rank hold MREO as of Q2 2025.

BIT Capital reported no remaining Mereo BioPharma position as of Q2 2025 after selling out during the quarter.
BIT Capital sold 101,070 Mereo BioPharma shares in Q2 2025, an estimated $227K.
BIT Capital first reported a position in Mereo BioPharma in Q1 2025 and held it in 1 quarter.
BIT Capital's Mereo BioPharma position peaked at $227K in Q1 2025.
86 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2025.

Based on BIT Capital's 13F filing for Q2 2025, filed 8 Aug 2025.